Major head and neck reconstruction during the COVID-19 pandemic: The University of Pittsburgh approach.
Viran RanasingheLeila J MadySeungwon KimMatthew J FerrisUmamaheswar DuvvuriJonas T JohnsonMario G SolariShaum SridharanMark W KubikPublished in: Head & neck (2020)
The 2019 novel coronavirus (COVID-19) pandemic has created significant challenges to the delivery of care for patients with advanced head and neck cancer requiring multimodality therapy. Performing major head and neck ablative surgery and reconstruction is a particular concern given the extended duration and aerosolizing nature of these cases. In this manuscript, we describe our surgical approach to provide timely reconstructive care and minimize infectious risk to the providers, patients, and families.
Keyphrases
- healthcare
- end stage renal disease
- palliative care
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- pain management
- affordable care act
- patient reported outcomes
- coronary artery disease
- mesenchymal stem cells
- bone marrow
- acute coronary syndrome
- percutaneous coronary intervention
- surgical site infection
- replacement therapy